-
EP3974443
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3974443
| EP3974443 - PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN B2 (MAGEB2) [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.11.2023 Database last updated on 11.01.2025 | |
| Former | The application has been published Status updated on 25.02.2022 | Most recent event Tooltip | 17.11.2023 | Application deemed to be withdrawn | published on 20.12.2023 [2023/51] | Applicant(s) | For all designated states Immunocore Limited 92 Park Drive Milton Park Abingdon, Oxfordshire OX14 4RY / GB | For all designated states Adaptimmune Limited 101 Park Drive Milton Park Abingdon, Oxfordshire OX14 4RY / GB | [2022/13] | Inventor(s) | 01 /
POWLESLAND, Alex Abingdon, OX14 4RY / GB | 02 /
CHESTER, Fiona Abingdon, OX14 4RY / GB | [2022/13] | Representative(s) | Lee, Nicholas John, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2022/13] | Application number, filing date | 21183259.7 | 23.11.2016 | [2022/13] | Priority number, date | GB20150020544 | 23.11.2015 Original published format: GB 201520544 | [2022/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3974443 | Date: | 30.03.2022 | Language: | EN | [2022/13] | Type: | A3 Search report | No.: | EP3974443 | Date: | 11.01.2023 | Language: | EN | [2023/02] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.12.2022 | Classification | IPC: | C07K14/47, C07K4/12, C07K7/06 | [2022/13] | CPC: |
C07K14/4748 (EP,US);
C07K14/7051 (US);
C07K14/70539 (US);
C07K16/30 (US);
C07K7/06 (EP,US);
C07K7/08 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/13] | Title | German: | VOM MELANOM-ASSOZIIERTEN ANTIGEN B2 (MAGEB2) ABGELEITETE PEPTIDE | [2022/13] | English: | PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN B2 (MAGEB2) | [2022/13] | French: | PEPTIDES DÉRIVÉS DE L'ANTIGÈNE B2 ASSOCIÉ AU MÉLANOME (MAGEB2) | [2022/13] | Examination procedure | 12.07.2023 | Application deemed to be withdrawn, date of legal effect [2023/51] | 01.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2023/51] | Parent application(s) Tooltip | EP16805193.6 / EP3380502 | Fees paid | Renewal fee | 29.10.2021 | Renewal fee patent year 03 | 29.10.2021 | Renewal fee patent year 04 | 29.10.2021 | Renewal fee patent year 05 | 26.05.2022 | Renewal fee patent year 06 | 18.11.2022 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.11.2021 | 06 M06 Fee paid on 26.05.2022 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]JPH06261941 (KURARAY CO); | [XA]WO2008027800 (UNIV TEMPLE [US], et al); | [XA]WO2010037395 (DAKO DENMARK AS [DK], et al); | [XA]WO2013040142 (IOGENETICS LLC [US], et al); | [XA]WO2014118236 (MAX DELBRÜCK CT FÜR MOLEDULARE MEDIZIN MDC BERLIN BUCH [DE]) | by applicant | EP0120694 | EP0125023 | EP0184187 | EP0239400 | GB2188638 | US5225539 | WO9413804 | WO9918129 | WO9936569 | WO02072631 | WO03020763 | WO2004044004 | WO2007143104 | WO2010133828 | WO2015136072 | WO1992US09965 | WO2016EP71757 | WO2016EP71761 | WO2016EP71762 | WO2016EP71765 | WO2016EP71767 | WO2016EP71768 | WO2016EP71771 | WO2016EP71772 |